GO Term | Evidence Code | PMID |
---|---|---|
inflammatory response | ||
lipid metabolic process | ||
signal transduction | ||
negative regulation of cell migration | ||
negative regulation of glutamate secretion |
GO Term | Evidence Code | PMID |
---|---|---|
extracellular space | ||
extracellular region | ||
centrosome | ||
nucleoplasm | ||
cytosol |
GO Term | Evidence Code | PMID |
---|---|---|
interleukin-1, type I receptor binding | ||
interleukin-1 receptor antagonist activity | ||
interleukin-1 type I receptor antagonist activity | ||
interleukin-1, type II receptor binding | ||
interleukin-1 type II receptor antagonist activity |
DO ID | Disease Name | Source |
---|---|---|
DOID:633 | myositis | |
DOID:6432 | pulmonary hypertension | |
DOID:7148 | rheumatoid arthritis | |
DOID:783 | end stage renal disease | |
DOID:784 | chronic kidney disease | |
DOID:824 | periodontitis | |
DOID:8552 | chronic myeloid leukemia | |
DOID:8577 | ulcerative colitis | |
DOID:8924 | autoimmune thrombocytopenic purpura | |
DOID:8927 | learning disability |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.1.1
Last updated: February 17, 2025